posted on Nov, 10 2004 @ 07:12 AM
LTD, an Indian drug producer has removed seven of its AIDS generic drugs from the approved list of the WHO. The company did this because they could
not guarantee that the potency of their drugs was as equal to the higher priced name brand drugs (IMG:CTV)
Ranbaxy Laboratories Ltd. of India removed seven drugs from the WHO list of "prequalified" medicines because it could not guarantee they were as
potent as more expensive brand-name versions. The WHO reached a similar conclusion in August about three other drugs made by the company
The Bush administration's $15 billion five-year global AIDS plan does not automatically recognize drugs on the WHO list. Instead, the administration
has said that generic AIDS drugs bought with U.S. grants must be approved first by the Food and Drug Administration
Please visit the link provided for the complete story.
This situation seems to fall in line with the Bush administration's reluctance to pay for these "low cost" drugs, the US does not automatically
recognize the WHO (World Health Organization) list for generics, the US pays for generics after approval of the FDA.
Related News Links:
[edit on 11/10/04 by JacKatMtn]